NDC 55466-149-22 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55466-149
- Requested NDC
- 55466-149-22
- Package NDCs from labels
- 55466-149-22
- Manufacturer
- Neolpharma, Inc.
- Effective date
- 2024-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Neolpharma, Inc. | Neolpharma, Inc. | 2024-05-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55466-149-22 | Oseltamivir Phosphate | 10 in 1 BOTTLE | CAPSULE | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 1f754ad7-9df0-4121-8051-0a09491be3c7 | 2022-09-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | c754c2f7-7109-4498-aeee-c8ee088dfa98 | 2022-09-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR | Amneal Pharmaceuticals NY LLC | d306e22c-0cb8-46cb-9a40-8194a2bc9e85 | 2022-08-30 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 8d264c73-4dd9-4f7c-8a18-f31195cdd013 | 2022-08-01 | Warnings, Adverse reactions | 728113 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Camber Pharmaceuticals, Inc. | 5c959361-8f08-4c65-968f-404a44422133 | 2022-06-02 | Warnings, Adverse reactions | 4A3O49NGEZ |
| oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Novadoz Pharmaceuticals LLC | 46dda802-32b8-4608-8eae-97e2cfc57472 | 2022-05-16 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 196c8dee-342b-4627-b060-39b99ed91a41 | 2022-05-02 | Warnings, Adverse reactions | 728113 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | de553d49-38c3-4fad-8582-d4d27c3c26b1 | 2022-05-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | Proficient Rx LP | ccdb124d-fd56-409a-8615-ae0f675cd8e4 | 2020-02-01 | Warnings, Adverse reactions | 728113 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Camber Pharmaceuticals, Inc. | 2a673aa2-e8f0-4aa4-8782-6fb3067ff108 | 2018-03-07 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.